, Carl Radosivech, Panasonic Healthcare Corporation of North America.

O2 Control in the Cell Culture Incubator

Guest commentary by Bill White

Dr. George Karlin-Neuman, Director of Scientific Affairs with the Bio-Rad Digital Biology Center in Pleasanton, California.

Dr. George Karlin-Neuman - Presented by Bio-Rad

Mica Zaragoza, Consultant, Global Custom Manufacturing & OEM Solutions, Promega Corporation, discusses the company's standard and custom product development and consultative services associated with biotechnology and molecular biology research and drug discovery.

Promega Custom Solutions for Drug Discovery

Walter Kolch, co-founder and director of Systems Biology Ireland discusses the merits of a network approach to target validation and why probing clinical samples early is critical to increasing drug development success.

DDN - Horizon - Walter Kolch

John Moffat, senior scientist in Biochemical and Cellular Pharmacology at Genentech, discusses the target validation and prioritization opportunities revealed at the crossroads of target-focused and phenotypic profiling approaches.

DDN - Horizon - John Moffat

Gosia Trynka, Group Leader at The Sanger Institute and Experimental Science Director at Open Targets, talks about the importance of cellular context for translating genomic and transcriptomic insights into actionable targets.

DDN – Horizon – Gosia Trynka

DDN Radio is a service of DDNews Magazine, the industry’s leading print and online source of information about the technology and business of pharmaceutical and biotechnology research.

DDN News

Popular tracks